Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ELABS.OL Stock Summary
In the News
ELABS.OL Financial details
Company Rating
Sell
Market Cap
1.5B
Income
-38M
Revenue
68.32M
Book val./share
2.91
Cash/share
1.09
Dividend
-
Dividend %
-
Employees
72
Optionable
No
Shortable
Yes
Earnings
23 May 2024
P/E
-44.65
Forward P/E
-
PEG
-37.7
P/S
25.33
P/B
5.1
P/C
12.83
P/FCF
-22.31
Quick Ratio
6.1
Current Ratio
10.65
Debt / Equity
0.03
LT Debt / Equity
0.01
-
-
EPS (TTM)
-0.36
EPS next Y
-
EPS next Q
-
EPS this Y
12.5%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
22.59%
Revenue last 5Y
12.47%
Revenue Q/Q
-57.87%
EPS Q/Q
186.58%
-
-
-
-
SMA20
-3.62%
SMA50
-14.33%
SMA100
-18.16%
Inst Own
-
Inst Trans
-
ROA
-10%
ROE
-11%
ROC
-0.12%
Gross Margin
-10%
Oper. Margin
-62%
Profit Margin
-54%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
10.22-19.86
52W High
-26.42%
52W Low
+39.8%
RSI
40.3
Rel Volume
0.27
Avg Volume
135.08K
Volume
35.83K
Perf Week
-1.69%
Perf Month
-7.42%
Perf Quarter
-14.86%
Perf Half Y
-15.78%
-
-
-
-
Beta
0.707
-
-
Volatility
0.14%, 0.39%
Prev Close
0.43%
Price
13.98
Change
-0.14%
ELABS.OL Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.38 | 0.34 | 0.56 | 0.5 | 0.65 | |
Net income per share | -0.13 | -0.14 | -0.11 | -0.32 | -0.36 | |
Operating cash flow per share | -0.08 | -0.07 | -0.11 | -0.12 | -0.36 | |
Free cash flow per share | -0.19 | -0.24 | -0.29 | -0.35 | -0.61 | |
Cash per share | 0.32 | 1.1 | 2.21 | 1.7 | 1.09 | |
Book value per share | 0.79 | 2.11 | 3.49 | 3.13 | 2.91 | |
Tangible book value per share | 0.63 | 1.79 | 3.11 | 2.67 | 2.91 | |
Share holders equity per share | 0.79 | 2.11 | 3.49 | 3.13 | 2.91 | |
Interest debt per share | 0.51 | 0.29 | 0.19 | 0.13 | 0.18 | |
Market cap | 1.55B | 1.12B | 2.73B | 2.29B | 1.8B | |
Enterprise value | 1.57B | 1.05B | 2.53B | 2.13B | 1.71B | |
P/E ratio | -116.96 | -89.89 | -243.32 | -69.47 | -47.33 | |
Price to sales ratio | 40.85 | 37.22 | 49.98 | 44.03 | 26.33 | |
POCF ratio | -192.68 | -168.38 | -252.13 | -179.69 | -46.91 | |
PFCF ratio | -80.99 | -51.63 | -95.97 | -63.53 | -27.96 | |
P/B Ratio | 19.37 | 5.98 | 7.96 | 7.04 | 5.86 | |
PTB ratio | 19.37 | 5.98 | 7.96 | 7.04 | 5.86 | |
EV to sales | 41.27 | 34.72 | 46.32 | 40.89 | 25.01 | |
Enterprise value over EBITDA | -159.56 | -141.67 | -705.41 | -79.58 | -37.89 | |
EV to operating cash flow | -194.65 | -157.1 | -233.68 | -166.86 | -44.57 | |
EV to free cash flow | -81.82 | -48.17 | -88.95 | -58.99 | -26.56 | |
Earnings yield | -0.01 | -0.01 | 0 | -0.01 | -0.02 | |
Free cash flow yield | -0.01 | -0.02 | -0.01 | -0.02 | -0.04 | |
Debt to equity | 0.61 | 0.12 | 0.05 | 0.04 | 0.03 | |
Debt to assets | 0.35 | 0.11 | 0.05 | 0.04 | 0.03 | |
Net debt to EBITDA | -1.62 | 10.18 | 55.7 | 6.12 | 1.99 | |
Current ratio | 1.43 | 8.93 | 14.67 | 13.13 | 7.45 | |
Interest coverage | -4.72 | -3.72 | -9.31 | -34.11 | -5.35 | |
Income quality | 0.47 | 0.43 | 0.83 | 0.32 | 1.01 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.14 | 0.19 | 0.1 | 0.11 | 0 | |
Research and developement to revenue | 0 | 0 | 0.1 | 0.16 | 0.17 | |
Intangibles to total assets | 0.12 | 0.13 | 0.1 | 0.14 | 0 | |
Capex to operating cash flow | 1.38 | 2.26 | 1.63 | 1.83 | 0.68 | |
Capex to revenue | -0.29 | -0.5 | -0.32 | -0.45 | -0.38 | |
Capex to depreciation | -2.53 | -2.78 | -2.12 | -2.06 | -5.61 | |
Stock based compensation to revenue | 0.08 | 0.13 | 0.19 | 0.24 | 0 | |
Graham number | 1.53 | 2.58 | 2.99 | 4.73 | 4.85 | |
ROIC | -0.08 | -0.04 | -0.03 | -0.1 | -0.12 | |
Return on tangible assets | -0.11 | -0.07 | -0.03 | -0.11 | -0.11 | |
Graham Net | -0.09 | 0.94 | 2.28 | 1.82 | 1.19 | |
Working capital | 17.17M | 107.99M | 246.89M | 208.44M | 160.72M | |
Tangible asset value | 63.48M | 159.86M | 306.21M | 278.05M | 307.11M | |
Net current asset value | -2.04M | 90.98M | 236.36M | 201.92M | 142.84M | |
Invested capital | 0.61 | 0.12 | 0.05 | 0.04 | 0.03 | |
Average receivables | 17.9M | 19.63M | 32.47M | 47.03M | 58.7M | |
Average payables | 1.68M | 911.76K | 2.01M | 2.35M | 2.76M | |
Average inventory | 1.56M | 3.97M | 3.06M | 1.55M | 891K | |
Days sales outstanding | 202.32 | 220.18 | 312.34 | 331.89 | 374.29 | |
Days payables outstanding | 6.67 | 10.06 | 21.76 | 9.69 | 15.66 | |
Days of inventory on hand | 25.02 | 48.9 | 9.51 | 10.36 | 0 | |
Receivables turnover | 1.8 | 1.66 | 1.17 | 1.1 | 0.98 | |
Payables turnover | 54.69 | 36.27 | 16.77 | 37.65 | 23.31 | |
Inventory turnover | 14.59 | 7.46 | 38.37 | 35.24 | 0 | |
ROE | -0.17 | -0.07 | -0.03 | -0.1 | -0.12 | |
Capex per share | -0.11 | -0.17 | -0.18 | -0.22 | -0.25 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.09 | 0.04 | 0.32 | 0.21 | 0.09 | |
Net income per share | -0.18 | -0.14 | 0.04 | -0.07 | -0.19 | |
Operating cash flow per share | -0.11 | -0.16 | -0.12 | -0.11 | 0.02 | |
Free cash flow per share | -0.18 | -0.22 | -0.18 | -0.17 | -0.04 | |
Cash per share | 1.7 | 1.47 | 1.25 | 1.13 | 1.09 | |
Book value per share | 3.13 | 3.02 | 3.09 | 3.09 | 2.91 | |
Tangible book value per share | 2.67 | 2.54 | 2.59 | 2.57 | 2.91 | |
Share holders equity per share | 3.13 | 3.02 | 3.09 | 3.09 | 2.91 | |
Interest debt per share | 0.08 | 0.11 | 0.1 | 0.28 | 0.15 | |
Market cap | 2.29B | 1.57B | 1.53B | 1.57B | 1.8B | |
Enterprise value | 2.13B | 1.43B | 1.41B | 1.48B | 1.71B | |
P/E ratio | -30.01 | -26.37 | 95.56 | -56.59 | -22.29 | |
Price to sales ratio | 232.79 | 388.03 | 46.05 | 71.7 | 195.17 | |
POCF ratio | -199.12 | -94.5 | -127.07 | -134.5 | 743.58 | |
PFCF ratio | -121.36 | -69.16 | -81.88 | -87.11 | -399.54 | |
P/B Ratio | 7.04 | 5 | 4.75 | 4.85 | 5.86 | |
PTB ratio | 7.04 | 5 | 4.75 | 4.85 | 5.86 | |
EV to sales | 216.16 | 353.07 | 42.4 | 67.56 | 185.44 | |
Enterprise value over EBITDA | -88.81 | -103.15 | 168.73 | -302.91 | -79.24 | |
EV to operating cash flow | -184.9 | -85.98 | -117 | -126.74 | 706.49 | |
EV to free cash flow | -112.69 | -62.93 | -75.38 | -82.09 | -379.61 | |
Earnings yield | -0.01 | -0.01 | 0 | 0 | -0.01 | |
Free cash flow yield | -0.01 | -0.01 | -0.01 | -0.01 | 0 | |
Debt to equity | 0.04 | 0.04 | 0.03 | 0.09 | 0.03 | |
Debt to assets | 0.04 | 0.03 | 0.03 | 0.08 | 0.03 | |
Net debt to EBITDA | 6.83 | 10.21 | -14.53 | 18.54 | 4.16 | |
Current ratio | 13.13 | 12.48 | 13.67 | 10.65 | 7.45 | |
Interest coverage | 3.85 | -28.28 | 5.14 | -5.04 | -3.75 | |
Income quality | 0.5 | 0.9 | -2 | 1.35 | -0.12 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.14 | 0.38 | 0.08 | 0.1 | 0 | |
Research and developement to revenue | 0.21 | 0.72 | 0.09 | 0.13 | 0.31 | |
Intangibles to total assets | 0.14 | 0.15 | 0.15 | 0.15 | 0 | |
Capex to operating cash flow | 0.64 | 0.37 | 0.55 | 0.54 | -2.86 | |
Capex to revenue | -0.75 | -1.5 | -0.2 | -0.29 | -0.75 | |
Capex to depreciation | -2.33 | -1.64 | -1.77 | -1.42 | -4.92 | |
Stock based compensation to revenue | 0.3 | 0.74 | 0.11 | 0.08 | 0 | |
Graham number | 3.6 | 3.12 | 1.63 | 2.15 | 3.54 | |
ROIC | -0.04 | -0.06 | 0.01 | -0.02 | -0.05 | |
Return on tangible assets | -0.06 | -0.05 | 0.01 | -0.02 | -0.06 | |
Graham Net | 1.82 | 1.62 | 1.61 | 1.38 | 1.19 | |
Working capital | 208.44M | 187.68M | 194.61M | 186.67M | 160.72M | |
Tangible asset value | 278.05M | 264.3M | 269.96M | 268.78M | 307.11M | |
Net current asset value | 201.92M | 182.12M | 190.07M | 166.97M | 142.84M | |
Invested capital | 0.04 | 0.04 | 0.03 | 0.09 | 0.03 | |
Average receivables | 44.21M | 48.71M | 63.22M | 81.43M | 78.28M | |
Average payables | 1.42M | 1.35M | 1.32M | 2.65M | 3.77M | |
Average inventory | 891K | 891K | 0 | 0 | 0 | |
Days sales outstanding | 432.63 | 1.11K | 207.14 | 355.86 | 684.18 | |
Days payables outstanding | 8.86 | 4.86 | 7.55 | 16.11 | 14.19 | |
Days of inventory on hand | 9.47 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.21 | 0.08 | 0.43 | 0.25 | 0.13 | |
Payables turnover | 10.15 | 18.51 | 11.92 | 5.59 | 6.34 | |
Inventory turnover | 9.5 | 0 | 0 | 0 | 0 | |
ROE | -0.06 | -0.05 | 0.01 | -0.02 | -0.07 | |
Capex per share | -0.07 | -0.06 | -0.06 | -0.06 | -0.07 |
ELABS.OL Frequently Asked Questions
What is Elliptic Laboratories ASA stock symbol ?
Elliptic Laboratories ASA is a NO stock and trading under the symbol ELABS.OL
What is Elliptic Laboratories ASA stock quote today ?
Elliptic Laboratories ASA stock price is $13.98 today.
Is Elliptic Laboratories ASA stock public?
Yes, Elliptic Laboratories ASA is a publicly traded company.